These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15021445

  • 1. Androgens, insulin-like growth factor-I (IGF-I), and carrier proteins (SHBG, IGFBP-3) in postmenopause.
    Gambera A, Scagliola P, Falsetti L, Sartori E, Bianchi U.
    Menopause; 2004; 11(2):159-66. PubMed ID: 15021445
    [Abstract] [Full Text] [Related]

  • 2. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
    Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P, Kaaks R.
    Eur J Endocrinol; 2004 Feb; 150(2):161-71. PubMed ID: 14763914
    [Abstract] [Full Text] [Related]

  • 3. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A, Kaufman JM, Giagulli VA.
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [Abstract] [Full Text] [Related]

  • 4. Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients.
    Lønning PE, Helle SI, Johannessen DC, Adlercreutz H, Lien EA, Tally M, Ekse D, Fotsis T, Anker GB, Hall K.
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):23-30. PubMed ID: 7534218
    [Abstract] [Full Text] [Related]

  • 5. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
    Cao YK, Zhang SF, Zou SE, Xia X, Xu LN.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
    [Abstract] [Full Text] [Related]

  • 6. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ, Fisker S, Gravholt CH, Bennett P, Svenstrup B, Andersen M, Feldt-Rasmussen U, Christiansen JS, Jørgensen JO.
    Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
    [Abstract] [Full Text] [Related]

  • 7. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
    Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS.
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
    [Abstract] [Full Text] [Related]

  • 8. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 9. Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.
    Harrington LB, Marck BT, Wiggins KL, McKnight B, Heckbert SR, Woods NF, LaCroix AZ, Blondon M, Psaty BM, Rosendaal FR, Matsumoto AM, Smith NL.
    J Thromb Haemost; 2017 Jan; 15(1):80-90. PubMed ID: 27797446
    [Abstract] [Full Text] [Related]

  • 10. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
    Genazzani AD, Stomati M, Strucchi C, Puccetti S, Luisi S, Genazzani AR.
    Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
    [Abstract] [Full Text] [Related]

  • 11. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
    Stomati M, Hartmann B, Spinetti A, Mailand D, Rubino S, Albrecht A, Huber J, Petraglia F, Genazzani AR.
    J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
    [Abstract] [Full Text] [Related]

  • 12. Androgen and SHBG serum concentrations in late post-menopause women.
    Skałba P, Wójtowicz M, Sikora J.
    Med Sci Monit; 2003 Mar; 9(3):CR152-6. PubMed ID: 12640346
    [Abstract] [Full Text] [Related]

  • 13. The relationship between ovarian structure and serum insulin, insulin-like growth factor-I (IGF-I) and its binding protein (IGFBP-1 and IGFBP-3) levels in premature pubarche.
    Teixeira RJ, Silva VC, Gazolla HM, Cunha SB, Guimarães MM.
    J Pediatr Endocrinol Metab; 2002 Jan; 15(1):69-75. PubMed ID: 11826868
    [Abstract] [Full Text] [Related]

  • 14. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J.
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
    [Abstract] [Full Text] [Related]

  • 15. Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels.
    Tworoger SS, Mantzoros C, Hankinson SE.
    Obesity (Silver Spring); 2007 Sep; 15(9):2217-24. PubMed ID: 17890489
    [Abstract] [Full Text] [Related]

  • 16. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AM.
    Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
    [Abstract] [Full Text] [Related]

  • 17. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
    Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT.
    Int J Cancer; 2007 Dec 01; 121(11):2506-11. PubMed ID: 17657735
    [Abstract] [Full Text] [Related]

  • 18. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Fertil Steril; 2001 Mar 01; 75(3):554-9. PubMed ID: 11239541
    [Abstract] [Full Text] [Related]

  • 19. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J, Zgliczynski S, Jeske W, Stopinska-Gluszak U, Srzednicki M, Brzezinska A, Zgliczynski W, Sadowski Z.
    J Endocrinol Invest; 1992 Mar 01; 15(7):533-8. PubMed ID: 1280287
    [Abstract] [Full Text] [Related]

  • 20. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
    Genazzani AD, Stomati M, Bernardi F, Pieri M, Rovati L, Genazzani AR.
    Fertil Steril; 2003 Dec 01; 80(6):1495-501. PubMed ID: 14667889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.